Time to Adjuvant Chemotherapy and Its Predictors Among Women with Breast Cancer at the University of Gondar Compressive Specialized Hospital: A Retrospective Follow-Up Study
Adugnaw Zeleke Alem, Ejigu Gebeye Zeleke, Temesgen Yihunie Akalu Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Science, University of Gondar, Gondar, EthiopiaCorrespondence: Adugnaw Zeleke Alem Email aduzeleke2201@gmail.comBackground: Early...
Enregistré dans:
Auteurs principaux: | Zeleke Alem A, Gebeye Zeleke E, Akalu TY |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/19f08aa655dc400e86dfdbf03757415f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival
par: Bin Huang, et autres
Publié: (2021) -
Integrative Radiogenomics Approach for Risk Assessment of Postoperative and Adjuvant Chemotherapy Benefits for Gastric Cancer Patients
par: Yin Jin, et autres
Publié: (2021) -
Adjuvant systemic therapy in older women with breast cancer
par: Leone J, et autres
Publié: (2016) -
The Results and Outcomes of Rectal Cancer Treatment in the Era of Adjuvant Chemoradiation
par: Ahmad Izadpanah, et autres
Publié: (2019) -
Inmunohistoquímica convencional como predictor de respuesta y sobrevida en pacientes con cáncer de mama tratadas con quimioterapia preoperatoria: Experiencia de un centro
par: Acevedo,Francisco, et autres
Publié: (2015)